Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application

Vaccine
Antonella CaputoBarbara Ensoli

Abstract

Two novel classes of biocompatible core-shell anionic microspheres, composed of an inner hard insoluble core, either made of poly(styrene) (PS) or poly(methyl methacrylate) (PMMA), and a soft outer tentacular shell made of long soluble negatively charged arms derived from the steric stabilizer, hemisuccinated poly(vinyl alcohol) or Eudragit L100/55, respectively, were prepared by dispersion polymerization and characterized. Five types of these novel microspheres, two made of poly(styrene) and hemisuccinated poly(vinyl alcohol) (A4 and A7), and three made of poly(methyl methacrylate) and Eudragit L100/55 (1D, 1E, H1D), differing for chemical composition, size, and surface charge density were analyzed for the delivery of the HIV-1 Tat protein for vaccine applications. All microspheres reversibly adsorbed the native biologically active HIV-1 Tat protein preventing Tat from oxidation and maintaining its biological activity, therefore increasing the shelf-life of the Tat protein vaccine. The microspheres efficiently delivered Tat intracellularly, and were not toxic in vitro nor in mice, even after multiple administrations. These results indicate that these novel microparticles are safe and represent a promising delivery system for v...Continue Reading

References

Jun 1, 1992·Research in Immunology·J H EldridgeR M Gilley
Oct 1, 1991·Vaccine·D T O'HaganS S Davis
Apr 1, 1981·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S M HsuH Fanger
Jul 17, 1995·Biochimica Et Biophysica Acta·G F Kersten, D J Crommelin
Jan 1, 1995·Journal of Drug Targeting·P G JenkinsS S Davis
Mar 18, 1994·Science·R GrefR Langer
Jul 1, 1996·Journal of Biomedical Materials Research·R Fernández-UrrusunoP Couvreur
Dec 1, 1996·Journal of Pharmaceutical Sciences·Z Zhao, K W Leong
Mar 21, 1998·The Journal of Pharmacy and Pharmacology·D T O'Hagan
Jul 27, 1999·Vaccine·A D OsterhausG Sutter
May 29, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·J KazzazD T O'Hagan
Jun 6, 2000·Advanced Drug Delivery Reviews·M S Shive, J M Anderson
Jun 6, 2000·Advanced Drug Delivery Reviews·R LangerJ Hanes
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·P JohansenB Gander
Mar 14, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·W ZaunerA M Haines
Jul 4, 2002·Proceedings of the National Academy of Sciences of the United States of America·S M AgwaleD M Hone
Jul 9, 2002·Immunology·Fabiola MichelettiRiccardo Gavioli
Nov 29, 2002·Current Drug Targets. Infectious Disorders·D T O'Hagan
Jan 28, 2003·Vaccine·Gideon F A Kersten, Daan J A Crommelin
Jun 19, 2004·Journal of Drug Targeting·J E EylesE D Williamson

❮ Previous
Next ❯

Citations

Feb 26, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Paola RimessiAlessandra Ferlini
Apr 1, 2005·Journal of Microencapsulation
Mar 16, 2007·Expert Opinion on Emerging Drugs·Emma J Bishop, Benjamin P Howden
Mar 2, 2006·Expert Opinion on Drug Delivery·Bhawna Gupta, Vladimir P Torchilin
Dec 25, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sheva NaahidiP Chen
Nov 27, 2007·Journal of Tissue Engineering and Regenerative Medicine·G A SilvaR L Reis
Mar 22, 2008·Journal of Biomedical Materials Research. Part a·Pei-Jen LouTai-Horng Young
Nov 25, 2004·Current Opinion in Biotechnology·Flavia FerrantelliBarbara Ensoli
Sep 26, 2006·Methods : a Companion to Methods in Enzymology·Derek T O'HaganJeffrey B Ulmer
Aug 24, 2006·International Journal of Pharmaceutics·Laura ChiarantiniLuisa Tondelli
Mar 28, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yasemin Ataman-OnalBernard Verrier
Dec 27, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Stefan FischerBruno Gander
Nov 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Laura ChiarantiniLuisa Tondelli
Oct 9, 2009·International Reviews of Immunology·Antonella CaputoBarbara Ensoli
Jan 19, 2012·Journal of Microencapsulation·Ana Bettencourt, António J Almeida
Apr 16, 2015·Human Vaccines & Immunotherapeutics·Valentina FinessiRiccardo Gavioli
Dec 22, 2005·Journal of Biomaterials Science. Polymer Edition·Katia SparnacciAntonella Caputo
Mar 7, 2013·Mycopathologia·Ruilong ChangBo Han
Mar 16, 2007·Expert Opinion on Emerging Drugs·Fausto TittiBarbara Ensoli
Jan 1, 2007·CSH Protocols·Dinesh B Shenoy, Mansoor M Amiji

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.